查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1706790

犬異位性皮膚炎市場－全球產業分析、規模、佔有率、成長、趨勢及預測（2025-2035）

Canine Atopic Dermatitis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 242 Pages | 商品交期: 2-10個工作天內

價格

犬特應性皮膚炎市場-報告範圍

TMR 關於全球犬異位性皮膚炎市場的報告研究了過去和當前的成長趨勢和機會，以獲得 2025 年至 2035 年預測期內市場指標的寶貴見解。該報告提供了 2019 年至 2035 年期間全球犬異位性皮膚炎市場的收入，以 2025 年為基準年，2035 年為預測年。該報告還提供了 2025 年至 2035 年全球犬異位性皮膚炎市場的年複合成長率(CAGR%)。

該報告是經過廣泛研究後編寫的。初步研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了訪談。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解犬異位性皮膚炎市場。

市場概況
2024 年的市場價值 2.314億美元
2035年的市場價值 4.31億美元
複合年成長率 5.8%

該報告深入探討了全球犬異位性皮膚炎市場的競爭格局。我們已經確定了在全球犬異位性皮膚炎市場中營運的關鍵參與者，並根據各種屬性對每個參與者進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告介紹的全球犬異位性皮膚炎市場參與者的屬性。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2035年全球市場分析與預測

第5章：關鍵見解

  • 主要國家醫療支出數據
  • 品牌和定價分析
  • 最新進展
  • 波特五力分析
  • 主要地區/國家的監管格局
  • 針對主要地區/國家新市場進入者的市場進入策略
  • 供應鏈分析
  • 價值鏈分析
  • 大環境分析
  • 主要潛在客戶

第6章：全球市場分析與預測：依產品類型

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年產品類型市場價值預測
    • 糖皮質激素
    • 免疫抑制劑
    • 單株抗體
    • 鈣調神經磷酸酶抑制劑
    • Janus激酶（JAK）抑制劑
    • 其他
  • 按產品類型分類的市場吸引力

第7章：全球市場分析與預測：依管理途徑

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年按給藥途徑分類的市場價值預測
    • 外用
    • 口服
    • 注射劑
  • 按給藥途徑分類的市場吸引力

第8章：全球市場分析與預測：按配銷通路

  • 介紹與定義
  • 主要發現/進展
  • 2020-2035年配銷通路市場價值預測
    • 獸醫醫院和診所
    • 獸醫藥房和藥房
    • 電子商務
    • 其他
  • 配銷通路的市場吸引力

第9章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各國家/地區市場吸引力

第10章：北美市場分析與預測

  • 美國
  • 加拿大

第 11 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區

第12章：亞太市場分析與預測

  • 中國
  • 日本
  • 印度
  • 澳洲和紐西蘭
  • 亞太其他地區

第13章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 阿根廷
  • 智利
  • 秘魯
  • 哥倫比亞
  • 拉丁美洲其他地區

第 14 章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：按公司（2024年）
  • 公司簡介
    • Zoetis
    • Merck & Co., Inc.
    • Elanco or its affiliates.
    • Boehringer Ingelheim International GmbH
    • Virbac Corporation
    • Vetoquinol
    • TORAY INDUSTRIES, INC.
    • Biocelix
    • Dechra Pharmaceuticals PLC
    • Bioiberica SAU
    • Ceva
    • Bimeda Corporate
    • Other prominent players
Product Code: TMRGL86479

Canine Atopic Dermatitis Market - Scope of Report

TMR's report on the global canine atopic dermatitis market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global canine atopic dermatitis market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global canine atopic dermatitis market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the canine atopic dermatitis market.

Market Snapshot
Market Value in 2024US$ 231.4 Mn
Market Value in 2035US$ 431 Mn
CAGR5.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global canine atopic dermatitis market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global canine atopic dermatitis market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global canine atopic dermatitis market.

The report delves into the competitive landscape of the global canine atopic dermatitis market. Key players operating in the global canine atopic dermatitis market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global canine atopic dermatitis market profiled in this report.

Key Questions Answered in Global canine atopic dermatitis Market Report:

  • What is the sales/revenue generated by canine atopic dermatitis across all regions during the forecast period?
  • What are the opportunities in the global canine atopic dermatitis market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Canine Atopic Dermatitis Market - Research Objectives and Research Approach

The comprehensive report on the global canine atopic dermatitis market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global canine atopic dermatitis market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global canine atopic dermatitis market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Canine Atopic Dermatitis Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Canine Atopic Dermatitis Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Healthcare Expenditure Data across Key Countries
  • 5.2. Brand and Pricing Analysis
  • 5.3. Recent Advancements in Canine Atopic Dermatitis
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. Regulatory Landscape across Key Regions / Countries
  • 5.6. Go-to-Market Strategy for New Market Entrants across Key Regions / Countries
  • 5.7. Supply Chain Analysis
  • 5.8. Value Chain Analysis
  • 5.9. PESTLE Analysis
  • 5.10. Key Potential Customers

6. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020-2035
    • 6.3.1. Glucocorticoids
    • 6.3.2. Immunosuppressants
    • 6.3.3. Monoclonal Antibodies
    • 6.3.4. Calcineurin Inhibitors
    • 6.3.5. Janus kinase (JAK) Inhibitor
    • 6.3.6. Others
  • 6.4. Market Attractiveness By Product Type

7. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Route of Administration, 2020-2035
    • 7.3.1. Topical
    • 7.3.2. Oral
    • 7.3.3. Injectable
  • 7.4. Market Attractiveness By Route of Administration

8. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Distribution Channel, 2020-2035
    • 8.3.1. Veterinary Hospitals and Clinics
    • 8.3.2. Veterinary Pharmacies & Drug Stores
    • 8.3.3. E-commerce
    • 8.3.4. Others
  • 8.4. Market Attractiveness By Distribution Channel

9. Global Canine Atopic Dermatitis Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Country/Region

10. North America Canine Atopic Dermatitis Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Product Type, 2020-2035
    • 10.2.1. Glucocorticoids
    • 10.2.2. Immunosuppressants
    • 10.2.3. Monoclonal Antibodies
    • 10.2.4. Calcineurin Inhibitors
    • 10.2.5. Janus kinase (JAK) Inhibitor
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Route of Administration, 2020-2035
    • 10.3.1. Topical
    • 10.3.2. Oral
    • 10.3.3. Injectable
  • 10.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 10.4.1. Veterinary Hospitals and Clinics
    • 10.4.2. Veterinary Pharmacies & Drug Stores
    • 10.4.3. E-commerce
    • 10.4.4. Others
  • 10.5. Market Value Forecast By Country, 2020-2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Route of Administration
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Canine Atopic Dermatitis Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product Type, 2020-2035
    • 11.2.1. Glucocorticoids
    • 11.2.2. Immunosuppressants
    • 11.2.3. Monoclonal Antibodies
    • 11.2.4. Calcineurin Inhibitors
    • 11.2.5. Janus kinase (JAK) Inhibitor
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Route of Administration, 2020-2035
    • 11.3.1. Topical
    • 11.3.2. Oral
    • 11.3.3. Injectable
  • 11.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 11.4.1. Veterinary Hospitals and Clinics
    • 11.4.2. Veterinary Pharmacies & Drug Stores
    • 11.4.3. E-commerce
    • 11.4.4. Others
  • 11.5. Market Value Forecast By Country, 2020-2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Route of Administration
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country

12. Asia Pacific Canine Atopic Dermatitis Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020-2035
    • 12.2.1. Glucocorticoids
    • 12.2.2. Immunosuppressants
    • 12.2.3. Monoclonal Antibodies
    • 12.2.4. Calcineurin Inhibitors
    • 12.2.5. Janus kinase (JAK) Inhibitor
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Route of Administration, 2020-2035
    • 12.3.1. Topical
    • 12.3.2. Oral
    • 12.3.3. Injectable
  • 12.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 12.4.1. Veterinary Hospitals and Clinics
    • 12.4.2. Veterinary Pharmacies & Drug Stores
    • 12.4.3. E-commerce
    • 12.4.4. Others
  • 12.5. Market Value Forecast By Country, 2020-2035
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Route of Administration
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country

13. Latin America Canine Atopic Dermatitis Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020-2035
    • 13.2.1. Glucocorticoids
    • 13.2.2. Immunosuppressants
    • 13.2.3. Monoclonal Antibodies
    • 13.2.4. Calcineurin Inhibitors
    • 13.2.5. Janus kinase (JAK) Inhibitor
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Route of Administration, 2020-2035
    • 13.3.1. Topical
    • 13.3.2. Oral
    • 13.3.3. Injectable
  • 13.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 13.4.1. Veterinary Hospitals and Clinics
    • 13.4.2. Veterinary Pharmacies & Drug Stores
    • 13.4.3. E-commerce
    • 13.4.4. Others
  • 13.5. Market Value Forecast By Country, 2020-2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Argentina
    • 13.5.4. Chile
    • 13.5.5. Peru
    • 13.5.6. Colombia
    • 13.5.7. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Route of Administration
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country

14. Middle East & Africa Canine Atopic Dermatitis Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020-2035
    • 14.2.1. Glucocorticoids
    • 14.2.2. Immunosuppressants
    • 14.2.3. Monoclonal Antibodies
    • 14.2.4. Calcineurin Inhibitors
    • 14.2.5. Janus kinase (JAK) Inhibitor
    • 14.2.6. Others
  • 14.3. Market Value Forecast By Route of Administration, 2020-2035
    • 14.3.1. Topical
    • 14.3.2. Oral
    • 14.3.3. Injectable
  • 14.4. Market Value Forecast By Distribution Channel, 2020-2035
    • 14.4.1. Veterinary Hospitals and Clinics
    • 14.4.2. Veterinary Pharmacies & Drug Stores
    • 14.4.3. E-commerce
    • 14.4.4. Others
  • 14.5. Market Value Forecast By Country, 2020-2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product Type
    • 14.6.2. By Route of Administration
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country

15. Competitive Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Zoetis
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Merck & Co., Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Elanco or its affiliates.
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Boehringer Ingelheim International GmbH
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Virbac Corporation
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Vetoquinol
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. TORAY INDUSTRIES, INC.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Biocelix
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Dechra Pharmaceuticals PLC
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Bioiberica S.A.U
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Ceva
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Bimeda Corporate
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Other prominent players
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments

List of Tables

  • Table 01: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 02: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 03: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 04: Global Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Region, 2020-2035
  • Table 05: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 06: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 07: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 08: North America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 09: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 10: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 11: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 12: Europe - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 13: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 14: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 15: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 16: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 18: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 19: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 20: Latin America - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035
  • Table 21: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 22: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Product Type, 2020-2035
  • Table 23: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, by Route of Administration, 2020-2035
  • Table 24: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Mn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Canine Atopic Dermatitis Market Value Share Analysis, by Product Type, 2024 and 2035
  • Figure 02: Global Canine Atopic Dermatitis Market Attractiveness Analysis, by Product Type, 2025-2035
  • Figure 03: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Glucocorticoids, 2020-2035
  • Figure 04: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Immunosuppressants, 2020-2035
  • Figure 05: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Monoclonal Antibodies, 2020-2035
  • Figure 06: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Calcineurin Inhibitors, 2020-2036
  • Figure 07: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Janus kinase (JAK) Inhibitor, 2020-2035
  • Figure 08: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 09: Global Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 10: Global Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 11: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Topical, 2020-2035
  • Figure 12: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Oral, 2020-2035
  • Figure 13: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Injectable, 2020-2035
  • Figure 14: Global Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 15: Global Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 16: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Veterinary Hospitals and Clinics, 2020-2035
  • Figure 17: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Veterinary Pharmacies & Drug Stores, 2020-2035
  • Figure 18: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by E-commerce, 2020-2035
  • Figure 19: Global Canine Atopic Dermatitis Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 20: Global Canine Atopic Dermatitis Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 21: Global Canine Atopic Dermatitis Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 22: North America - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 23: North America - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 24: North America - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 25: North America Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 26: North America Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 27: North America Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 28: North America Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 29: North America - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 30: North America - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 31: Europe - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 32: Europe - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 33: Europe - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 34: Europe Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 35: Europe Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 36: Europe Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 37: Europe Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 38: Europe - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 39: Europe - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 40: Asia Pacific - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 41: Asia Pacific - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 42: Asia Pacific - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 43: Asia Pacific Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 44: Asia Pacific Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 45: Asia Pacific Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 46: Asia Pacific Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 47: Asia Pacific - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 48: Asia Pacific - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 49: Latin America - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 50: Latin America - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 51: Latin America - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 52: Latin America Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 53: Latin America Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 54: Latin America Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 55: Latin America Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 56: Latin America - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 57: Latin America - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 58: Middle East & Africa - Canine Atopic Dermatitis Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 59: Middle East & Africa - Canine Atopic Dermatitis Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 60: Middle East & Africa - Canine Atopic Dermatitis Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 61: Middle East & Africa Canine Atopic Dermatitis Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 62: Middle East & Africa Canine Atopic Dermatitis Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 63: Middle East & Africa Canine Atopic Dermatitis Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 64: Middle East & Africa Canine Atopic Dermatitis Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 65: Middle East & Africa - Canine Atopic Dermatitis Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 66: Middle East & Africa - Canine Atopic Dermatitis Market Attractiveness Analysis, By Distribution Channel, 2025-2035